Company / Gross Margin
ATOSSA THERAPEUTICS, INC. Gross Margin History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
-7431.9%
FY2016
5-year range
-7431.9% / 100.0%
FY2012-FY2016
Trend
-7531.9%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin changed -7532% YoY in FY2016, a notable deviation from the 4-year average annual change of -1786%.
Based on SEC 10-K filings.
-7431.9% in FY2016 with a 3-year CAGR of -7518.3%.
Declined from 21.7% to -7431.9% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -7518.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, gross margin decreased 7531.9% year-over-year.
- Peak gross margin was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -7431.9% | -7531.9% |
| FY2015 | 100.0% | +361.5% |
| FY2014 | 21.7% | -74.9% |
| FY2013 | 86.4% | +101.4% |
| FY2012 | -6379.3% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026